# Generic Zoledronic Acid Versus Original Zoledronic Acid in Postmenopausal Osteoporotic Women

> **NCT03158246** · PHASE4 · UNKNOWN · sponsor: **Cttq** · enrollment: 466 (estimated)

## Conditions studied

- Osteoporosis, Postmenopausal

## Interventions

- **DRUG:** Generic Zoledronic Acid
- **DRUG:** Original Zoledronic Acid
- **DIETARY_SUPPLEMENT:** calcium
- **DIETARY_SUPPLEMENT:** vitamin D

## Key facts

- **NCT ID:** NCT03158246
- **Lead sponsor:** Cttq
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-06-01
- **Primary completion:** 2019-12-31
- **Final completion:** 2020-03-02
- **Target enrollment:** 466 (ESTIMATED)
- **Last updated:** 2017-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03158246

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03158246, "Generic Zoledronic Acid Versus Original Zoledronic Acid in Postmenopausal Osteoporotic Women". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03158246. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*